◆ 会议时间：2020年3月2-4日
◆ 会议地点：法国 巴黎
◆ 下届会议：2021年国际靶向抗癌治疗大会(ESMO TAT2021)
◆ 会议简介：
2020年第18届国际靶向抗癌治疗大会(TAT2020)将于2020年3月2-4日在法国巴黎举行，会议由欧洲肿瘤内科学会(ESMO)主办。靶向抗癌治疗(TAT)大会是ESMO官方年度会议，自2018年开始每年在欧洲举办。TAT会议是专注于讨论早期药物开发和转化研究的首要论坛，会议议题涵盖靶向药物、免疫肿瘤学和涉及此类药物的组合等方面。来自学术界和工业界的领导者、临床医生、研究人员和监管机构一起共同努力，加快开发新的抗癌治疗方法以提高患者的预后效果。
欧洲肿瘤内科学会（ESMO）成立于1975年，是欧洲领先的肿瘤内科学专业组织，现在全球150多个国家和地区拥有超过23,000名会员，是肿瘤学教育和信息的参考学会，ESMO致力于支持其会员在快速发展的专业环境中得到发展与进步。作为一个非营利组织，ESMO一直以推动癌症护理和治疗为使命，致力于推进肿瘤医学专业的发展，以多学科的方法来促进癌症的治疗和护理。—未经本站允许，禁止复制、转载、摘录本站任何内容，领域国际医学会议网。
摘要提交截止日期：
| Deadline |
Date and time |
| Abstracts |
7 January 2020, 19:00 CET (Central European Time |
The TAT Congress has firmly established itself as the must-attend forum for all experts focusing on early phase drug development and translational research.
Stakeholders from academia and industry meet with clinicians, researchers and regulators from all around the world to facilitate the development of new anti-cancer treatments and make more options available to patients.
The TAT Congress series has effectively transformed the landscape of early drug development and you have the opportunity to be a part of a highly influential meeting.
Participating in TAT 2020 will bring you outstanding networking opportunities, enlightening discussions and promising new partnerships.
We hope to see you at TAT 2020!
TAT 2020 注册费：
Registration fees
(20% VAT included) |
Early registration
until 20 January 2020 |
Late registration
until 12 February 2020 |
Full registration
from 13 February 2020 |
| ESMO Members |
€ 420.00 |
€ 492.00 |
€ 564.00 |
| ESMO Members in training |
€ 210.00 |
€ 210.00 |
€ 294.00 |
| Non-members in training |
€ 312.00 |
€ 312.00 |
€ 432.00 |
| Non-members academic/non-profit |
€ 636.00 |
€ 744.00 |
€ 840.00 |
| Industry delegates |
€ 900.00 |
€ 984.00 |
€ 1,092.00 |
| Small Biotech delegates |
€ 732.00 |
€ 732.00 |
€ 732.00 |
The registration fee comprises the following benefits
- Access to the Congress
- Delegate bag
- Webcasts
- Welcome reception
- Coffee breaks
- Lunch on Monday, Tuesday and Wednesday
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
